Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$17.8 - $23.5 $1.31 Million - $1.73 Million
-73,800 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$11.5 - $17.96 $17,250 - $26,940
-1,500 Reduced 1.99%
73,800 $1.32 Million
Q3 2020

Nov 05, 2020

BUY
$10.62 - $13.12 $18,054 - $22,304
1,700 Added 2.31%
75,300 $876,000
Q2 2020

Aug 12, 2020

BUY
$7.35 - $10.81 $33,075 - $48,645
4,500 Added 6.51%
73,600 $680,000
Q1 2020

May 12, 2020

SELL
$8.38 - $17.34 $54,470 - $112,710
-6,500 Reduced 8.6%
69,100 $719,000
Q4 2019

Jan 27, 2020

BUY
$11.18 - $18.6 $82,732 - $137,640
7,400 Added 10.85%
75,600 $1.35 Million
Q3 2019

Oct 31, 2019

BUY
$12.09 - $20.46 $119,691 - $202,554
9,900 Added 16.98%
68,200 $851,000
Q2 2019

Aug 15, 2019

SELL
$18.5 - $25.47 $1,850 - $2,547
-100 Reduced 0.17%
58,300 $1.15 Million
Q1 2019

May 03, 2019

SELL
$14.62 - $22.13 $392,722 - $594,456
-26,862 Reduced 31.51%
58,400 $1.23 Million
Q4 2018

Feb 08, 2019

SELL
$17.09 - $38.25 $270,739 - $605,956
-15,842 Reduced 15.67%
85,262 $1.74 Million
Q3 2018

Nov 13, 2018

BUY
$34.05 - $55.9 $770,585 - $1.27 Million
22,631 Added 28.84%
101,104 $3.73 Million
Q2 2018

Aug 15, 2018

SELL
$36.15 - $52.5 $1.75 Million - $2.54 Million
-48,304 Reduced 38.1%
78,473 $3.94 Million
Q1 2018

May 11, 2018

SELL
$24.4 - $40.25 $282,503 - $466,014
-11,578 Reduced 8.37%
126,777 $4.63 Million
Q4 2017

Feb 06, 2018

BUY
$18.5 - $28.6 $15,151 - $23,423
819 Added 0.6%
138,355 $3.92 Million
Q3 2017

Nov 15, 2017

BUY
$14.65 - $19.35 $2.01 Million - $2.66 Million
137,536
137,536 $2.66 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $749M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.